Parker-Hannifin Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Parker-Hannifin Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Jun 30, 2018 | $3.82B | Aug 24, 2018 |
| FY2018 | Mar 31, 2018 | $3.75B | Aug 24, 2018 |
| FY2018 | Dec 31, 2017 | $3.37B | Aug 24, 2018 |
| FY2018 | Sep 30, 2017 | $3.36B | Aug 24, 2018 |
| FY2018 | Jun 30, 2017 | $3.50B | Aug 24, 2018 |
| FY2018 | Mar 31, 2017 | $3.12B | Aug 24, 2018 |
| FY2018 | Dec 31, 2016 | $2.67B | Aug 24, 2018 |
| FY2018 | Sep 30, 2016 | $2.74B | Aug 24, 2018 |
| FY2018 | Jun 30, 2016 | $11.36B | Aug 24, 2018 |
| FY2017 | Jun 30, 2015 | $12.71B | Aug 25, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $19.85B | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $19.93B | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | $19.07B | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | $15.86B | Aug 22, 2024 |
| FY2023 | Jun 30, 2021 | $14.35B | Aug 24, 2023 |
| FY2020 | Jun 30, 2020 | $3.16B | Aug 26, 2020 |
| FY2020 | Mar 31, 2020 | $3.70B | Aug 26, 2020 |
| FY2020 | Dec 31, 2019 | $3.50B | Aug 26, 2020 |
| FY2020 | Sep 30, 2019 | $3.33B | Aug 26, 2020 |
| FY2020 | Jun 30, 2019 | $3.68B | Aug 26, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jun 30, 2017 | $3.50B | Aug 25, 2017 |
| FY2017 | Mar 31, 2017 | $3.12B | Aug 25, 2017 |
| FY2017 | Dec 31, 2016 | $2.67B | Aug 25, 2017 |
| FY2017 | Sep 30, 2016 | $2.74B | Aug 25, 2017 |
| FY2017 | Jun 30, 2016 | $2.96B | Aug 25, 2017 |
| FY2017 | Mar 31, 2016 | $2.83B | Aug 25, 2017 |
| FY2017 | Dec 31, 2015 | $2.71B | Aug 25, 2017 |
| FY2017 | Sep 30, 2015 | $2.87B | Aug 25, 2017 |
| FY2016 | Jun 30, 2015 | $3.14B | Aug 26, 2016 |
| FY2016 | Mar 31, 2015 | $3.16B | Aug 26, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jun 30, 2017 | $841.56M | Aug 25, 2017 |
| FY2017 | Mar 31, 2017 | $735.35M | Aug 25, 2017 |
| FY2017 | Dec 31, 2016 | $626.32M | Aug 25, 2017 |
| FY2017 | Sep 30, 2016 | $637.13M | Aug 25, 2017 |
| FY2017 | Jun 30, 2016 | $684.70M | Aug 25, 2017 |
| FY2017 | Mar 31, 2016 | $619.26M | Aug 25, 2017 |
| FY2017 | Dec 31, 2015 | $564.97M | Aug 25, 2017 |
| FY2017 | Sep 30, 2015 | $668.44M | Aug 25, 2017 |
| FY2016 | Jun 30, 2015 | $723.73M | Aug 26, 2016 |
| FY2016 | Mar 31, 2015 | $789.30M | Aug 26, 2016 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $2.84B | Aug 22, 2024 |
| FY2024 | Jun 30, 2023 | $2.08B | Aug 22, 2024 |
| FY2024 | Jun 30, 2022 | $1.32B | Aug 22, 2024 |
| FY2023 | Jun 30, 2021 | $1.75B | Aug 24, 2023 |
| FY2021 | Mar 31, 2021 | $473.15M | Aug 25, 2021 |
| FY2021 | Dec 31, 2020 | $448.35M | Aug 25, 2021 |
| FY2021 | Sep 30, 2020 | $319.80M | Aug 25, 2021 |
| FY2020 | Jun 30, 2020 | $295.72M | Aug 26, 2020 |
| FY2021 | Mar 31, 2020 | $372.60M | Aug 25, 2021 |
| FY2021 | Dec 31, 2019 | $201.93M | Aug 25, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $4.35B | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $4.07B | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | $3.40B | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | $2.98B | Aug 22, 2024 |
| FY2023 | Jun 30, 2021 | $2.46B | Aug 24, 2023 |
| FY2022 | Jun 30, 2020 | $1.97B | Aug 24, 2022 |
| FY2021 | Jun 30, 2019 | $2.24B | Aug 25, 2021 |
| FY2020 | Jun 30, 2018 | $2.04B | Aug 26, 2020 |
| FY2019 | Jun 30, 2017 | $1.79B | Aug 23, 2019 |
| FY2018 | Jun 30, 2016 | $1.58B | Aug 24, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $240.00M | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $253.00M | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | $258.00M | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | $191.00M | Aug 22, 2024 |
| FY2023 | Jun 30, 2021 | $205.00M | Aug 24, 2023 |
| FY2022 | Jun 30, 2020 | $237.00M | Aug 24, 2022 |
| FY2021 | Jun 30, 2019 | $294.85M | Aug 25, 2021 |
| FY2020 | Jun 30, 2018 | $327.88M | Aug 26, 2020 |
| FY2019 | Jun 30, 2017 | $336.68M | Aug 23, 2019 |
| FY2018 | Jun 30, 2016 | $359.80M | Aug 24, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $3.26B | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $3.32B | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | $3.35B | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | $2.50B | Aug 22, 2024 |
| FY2023 | Jun 30, 2021 | $2.38B | Aug 24, 2023 |
| FY2022 | Jun 30, 2020 | $1.66B | Aug 24, 2022 |
| FY2021 | Jun 30, 2019 | $1.54B | Aug 25, 2021 |
| FY2020 | Jun 30, 2018 | $1.64B | Aug 26, 2020 |
| FY2019 | Jun 30, 2017 | $1.41B | Aug 23, 2019 |
| FY2018 | Jun 30, 2016 | $1.36B | Aug 24, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $3.78B | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $3.38B | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | $2.98B | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | $2.44B | Aug 22, 2024 |
| FY2023 | Jun 30, 2021 | $2.58B | Aug 24, 2023 |
| FY2022 | Jun 30, 2020 | $2.07B | Aug 24, 2022 |
| FY2021 | Jun 30, 2019 | $1.73B | Aug 25, 2021 |
| FY2020 | Jun 30, 2018 | $1.60B | Aug 26, 2020 |
| FY2019 | Jun 30, 2017 | $1.30B | Aug 23, 2019 |
| FY2018 | Jun 30, 2016 | $1.21B | Aug 24, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $435.00M | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $400.00M | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | $381.00M | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | $230.04M | Aug 22, 2024 |
| FY2023 | Jun 30, 2021 | $209.96M | Aug 24, 2023 |
| FY2022 | Jun 30, 2020 | $232.59M | Aug 24, 2022 |
| FY2021 | Jun 30, 2019 | $195.09M | Aug 25, 2021 |
| FY2020 | Jun 30, 2018 | $247.67M | Aug 26, 2020 |
| FY2019 | Jun 30, 2017 | $203.75M | Aug 23, 2019 |
| FY2018 | Jun 30, 2016 | $149.41M | Aug 24, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $29.49B | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $29.30B | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | $29.96B | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | $25.94B | Aug 22, 2024 |
| FY2023 | Jun 30, 2021 | $20.34B | Aug 24, 2023 |
| FY2022 | Jun 30, 2020 | $19.89B | Aug 24, 2022 |
| FY2021 | Jun 30, 2019 | $17.73B | Aug 25, 2021 |
| FY2020 | Jun 30, 2018 | $15.32B | Aug 26, 2020 |
| FY2019 | Jun 30, 2017 | $15.49B | Aug 23, 2019 |
| FY2018 | Jun 30, 2016 | $12.03B | Aug 24, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $15.80B | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $17.22B | Aug 22, 2025 |
| FY2024 | Jun 30, 2023 | $19.63B | Aug 22, 2024 |
| FY2023 | Jun 30, 2022 | $17.08B | Aug 24, 2023 |
| FY2022 | Jun 30, 2021 | $11.93B | Aug 24, 2022 |
| FY2021 | Jun 30, 2020 | $13.65B | Aug 25, 2021 |
| FY2020 | Jun 30, 2019 | $11.61B | Aug 26, 2020 |
| FY2019 | Jun 30, 2018 | $9.45B | Aug 23, 2019 |
| FY2018 | Jun 30, 2017 | $10.22B | Aug 24, 2018 |
| FY2017 | Jun 30, 2016 | $7.46B | Aug 25, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $13.68B | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $12.07B | Aug 22, 2025 |
| FY2024 | Jun 30, 2023 | $10.33B | Aug 22, 2024 |
| FY2023 | Jun 30, 2022 | $8.85B | Aug 24, 2023 |
| FY2022 | Jun 30, 2021 | $8.40B | Aug 24, 2022 |
| FY2021 | Jun 30, 2020 | $6.23B | Aug 25, 2021 |
| FY2020 | Jun 30, 2019 | $5.96B | Aug 26, 2020 |
| FY2019 | Jun 30, 2018 | $5.86B | Aug 23, 2019 |
| FY2018 | Jun 30, 2017 | $5.26B | Aug 24, 2018 |
| FY2017 | Jun 30, 2016 | $4.58B | Aug 25, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $10.69B | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $10.51B | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | $10.63B | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | $7.74B | Aug 22, 2024 |
| FY2023 | Jun 30, 2021 | $8.06B | Aug 24, 2023 |
| FY2022 | Jun 30, 2020 | $7.87B | Aug 24, 2022 |
| FY2021 | Jun 30, 2019 | $5.45B | Aug 25, 2021 |
| FY2020 | Jun 30, 2018 | $5.50B | Aug 26, 2020 |
| FY2019 | Jun 30, 2017 | $5.59B | Aug 23, 2019 |
| FY2018 | Jun 30, 2016 | $2.90B | Aug 24, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $21.78B | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $19.11B | Aug 22, 2025 |
| FY2024 | Jun 30, 2023 | $17.04B | Aug 22, 2024 |
| FY2023 | Jun 30, 2022 | $15.66B | Aug 24, 2023 |
| FY2022 | Jun 30, 2021 | $14.92B | Aug 24, 2022 |
| FY2021 | Jun 30, 2020 | $13.64B | Aug 25, 2021 |
| FY2020 | Jun 30, 2019 | $12.78B | Aug 26, 2020 |
| FY2019 | Jul 1, 2018 | $11.63B | Aug 23, 2019 |
| FY2019 | Jun 30, 2018 | $11.63B | Aug 23, 2019 |
| FY2018 | Jun 30, 2017 | $10.93B | Aug 24, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $467.00M | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $422.00M | Aug 22, 2025 |
| FY2024 | Jun 30, 2023 | $475.18M | Aug 22, 2024 |
| FY2023 | Jun 30, 2022 | $535.80M | Aug 24, 2023 |
| FY2022 | Jun 30, 2021 | $733.12M | Aug 24, 2022 |
| FY2021 | Jun 30, 2020 | $685.51M | Aug 25, 2021 |
| FY2020 | Jun 30, 2019 | $3.22B | Aug 26, 2020 |
| FY2019 | Jun 30, 2018 | $822.14M | Aug 23, 2019 |
| FY2018 | Jun 30, 2017 | $884.89M | Aug 24, 2018 |
| FY2018 | Jun 30, 2016 | $1.22B | Aug 24, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $7.50B | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $8.41B | Aug 22, 2025 |
| FY2024 | Jun 30, 2023 | $10.77B | Aug 22, 2024 |
| FY2023 | Jun 30, 2022 | $10.06B | Aug 24, 2023 |
| FY2022 | Jun 30, 2021 | $6.58B | Aug 24, 2022 |
| FY2021 | Jun 30, 2020 | $7.74B | Aug 25, 2021 |
| FY2020 | Jun 30, 2019 | $6.52B | Aug 26, 2020 |
| FY2019 | Jun 30, 2018 | $4.42B | Aug 23, 2019 |
| FY2018 | Jun 30, 2017 | $5.34B | Aug 24, 2018 |
| FY2017 | Jun 30, 2016 | $2.73B | Aug 25, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 27 | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | 22 | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | 16 | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | 10 | Aug 22, 2024 |
| FY2023 | Jun 30, 2021 | 13 | Aug 24, 2023 |
| FY2021 | Mar 31, 2021 | 3 | Aug 25, 2021 |
| FY2021 | Dec 31, 2020 | 3 | Aug 25, 2021 |
| FY2021 | Sep 30, 2020 | 2 | Aug 25, 2021 |
| FY2022 | Jun 30, 2020 | 9 | Aug 24, 2022 |
| FY2021 | Mar 31, 2020 | 2 | Aug 25, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 27 | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | 21 | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | 16 | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | 10 | Aug 22, 2024 |
| FY2023 | Jun 30, 2021 | 13 | Aug 24, 2023 |
| FY2021 | Mar 31, 2021 | 3 | Aug 25, 2021 |
| FY2021 | Dec 31, 2020 | 3 | Aug 25, 2021 |
| FY2021 | Sep 30, 2020 | 2 | Aug 25, 2021 |
| FY2020 | Jun 30, 2020 | 2 | Aug 26, 2020 |
| FY2021 | Mar 31, 2020 | 2 | Aug 25, 2021 |